Neuronetics, Inc. (STIM) Ownership

NASDAQ: STIMTop holders, insider trades and short interest.

STIM ownership summary

as of October 17, 2026
Institutions
54.0%
of shares outstanding
Insiders
32.85%
of shares outstanding
Shares outstanding
76.2M
Float
37.2M
shares available to trade
Short interest
17.25%
7.1M shares short
Days to cover
5.64
short interest up 13.8% vs prior month
  • Institutions 53.96%
  • Insiders 32.85%
  • Other investors 13.19%

STIM top institutional holders

20 largest
Neuronetics, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Madryn Asset Management, LP24.33%18.5M$34.9M+64,595 (+0.3%)June 30, 2026
2UBS Group AG2.99%2.3M$4.3M−591,499 (−20.6%)June 30, 2026
3Wexford Capital LP2.63%2.0M$3.8M+1.3M (+185.7%)June 30, 2026
4FourWorld Capital Management LLC2.29%1.7M$3.3M+254,820 (+17.1%)June 30, 2026
5Lane Generational LLC2.14%1.6M$3.1M−141,252 (−8.0%)June 30, 2026
6Vanguard Capital Management, LLC1.98%1.5M$2.8M−540,878 (−26.4%)June 30, 2026
7Masters Capital Management LLC1.31%1.0M$1.9M—June 30, 2026
8AdvisorShares Investments, LLC0.97%743K$1.4M+125,602 (+20.4%)June 30, 2026
9Ikarian Capital, LLC0.92%701K$1.3M—June 30, 2026
10BlackRock Inc0.78%597K$1.1M−1.7M (−74.3%)June 30, 2026
11HighTower Advisors, LLC0.74%564K$1.1M+1,371 (+0.2%)June 30, 2026
12Marshall Wace Asset Management Ltd0.64%486K$915,529+485,692 (0.0%)June 30, 2026
13Geode Capital Management, LLC0.60%458K$864,223−500,515 (−52.2%)June 30, 2026
14Citadel Advisors Llc0.55%422K$795,287+345,306 (+450.8%)June 30, 2026
15Dauntless Investment Group, LLC0.48%369K$695,917+99,979 (+37.1%)June 30, 2026
16State Street Corp0.38%290K$547,214−552,248 (−65.5%)June 30, 2026
17Centiva Capital LP0.38%286K$538,946+116,594 (+68.9%)June 30, 2026
18Vanguard Fiduciary Trust Co0.35%265K$499,024+6,700 (+2.6%)June 30, 2026
19The Goldman Sachs Group Inc0.35%264K$497,806+30,498 (+13.1%)June 30, 2026
20JBF Capital, Inc.0.31%233K$439,518—June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 11 holders added 2.8M shares and 6 cut 4.0M.

STIM top mutual fund and ETF holders

17 largest
Neuronetics, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Vanguard MStar Total Stk Mkt Idx Invest1.39%1.1M$2.0M—August 31, 2026
2AdvisorShares Psychedelics ETF1.21%924K$1.7M—September 30, 2026
3Fidelity Nasdaq Composite Index0.29%220K$415,096+175,459 (+392.1%)August 31, 2026
4Fidelity Extended Market Index0.28%216K$407,793+16,538 (+8.3%)August 31, 2026
5EA Bridgeway Ultra-Small Company Mkt ETF0.12%90K$170,225—September 30, 2026
6Goldman Sachs Absolute Ret Trckr Instl0.11%87K$164,089+47,345 (+119.2%)June 30, 2026
7iShares Micro-Cap ETF0.11%84K$158,853−581 (−0.7%)September 30, 2026
8LUX IM Global Medtech HX0.10%79K$149,543—August 31, 2026
91290 VT GAMCO Small Company Value IB0.10%75K$141,375—August 31, 2026
10Fidelity Total Market Index0.09%71K$132,981+1,147 (+1.7%)August 31, 2026
11Fidelity Series Total Market Index0.08%59K$110,585—August 31, 2026
12Invesco NASDAQ Future Gen 200 ETF0.06%42K$79,600—September 30, 2026
13AQR Small Cap Momentum Style I0.05%36K$68,778+36,487 (0.0%)March 31, 2026
14Gabelli Small Cap Growth AAA0.04%30K$56,550—June 30, 2026
15Vanguard Balanced Index Inv0.03%26K$49,568—August 31, 2026
16Vanguard U.S. Eq Idx £ Acc0.02%16K$31,014—August 31, 2026
17Gabelli Global Mini Mites I0.01%8,000$15,080—June 30, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

STIM insider transactions

latest 15
Neuronetics, Inc. insider transactions
DateNameTransactionPriceSharesValue
2026-04-20Jorey ChernettBuy$1.58100,000$158,000
2026-03-20Jorey ChernettBuy$1.41169,472$238,956
2026-03-19Jorey ChernettBuy$1.33450,000$598,500
2026-03-19Keith J SullivanSell$1.3446,289$62,027
2026-03-19Steven PfanstielSell$1.3416,431$22,018
2026-03-19William Andrew MacanSell$1.3416,005$21,447
2026-03-18Jorey ChernettBuy$1.35607,400$819,990
2026-03-17Jorey ChernettBuy$1.16531,000$615,960
2026-02-26Keith J SullivanSell$1.358,452$11,410
2026-02-26William Andrew MacanSell$1.353,427$4,626
2026-02-12Keith J SullivanSell$1.6533,847$55,848
2026-02-12William Andrew MacanSell$1.6514,120$23,298
2026-02-10Keith J SullivanSell$1.5540,976$63,513
2026-02-10William Andrew MacanSell$1.553,485$5,402
2025-05-12Stephen FurlongSell$4.27193,460$826,074

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

STIM shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns STIM

Institutional investors own 54.0% of Neuronetics's shares and insiders 32.85%. The largest holder is Madryn Asset Management, LP with 24.33% of the shares (18.5M), as of June 30, 2026. Among the top 20 institutions, 11 added shares and 6 reduced their stake in the latest filings. Short interest is 17.25% of the float, or 5.64 days of average trading volume. The share count rose 613,792.9% since 2017.

Related: STIM analyst forecast, STIM key metrics. See the STIM stock overview for the latest quote and news.

STIM ownership FAQ

Who owns the most Neuronetics stock?

The largest shareholders of Neuronetics are Madryn Asset Management, LP (24.33%), UBS Group AG (2.99%), Wexford Capital LP (2.63%), FourWorld Capital Management LLC (2.29%), Lane Generational LLC (2.14%).

What percentage of Neuronetics is owned by institutions?

Institutions hold 54.0% of Neuronetics's shares outstanding; insiders hold 32.85%.

Which funds own Neuronetics?

The largest fund holders of Neuronetics are Vanguard MStar Total Stk Mkt Idx Invest (1.39%), AdvisorShares Psychedelics ETF (1.21%), Fidelity Nasdaq Composite Index (0.29%), Fidelity Extended Market Index (0.28%), EA Bridgeway Ultra-Small Company Mkt ETF (0.12%).

What is Neuronetics's short interest?

7.1M shares of Neuronetics were sold short, 17.25% of the float; at the average daily volume it would take 5.64 days to cover.

Are insiders buying or selling Neuronetics?

Of the latest 15 reported insider transactions in Neuronetics (since May 12, 2025), 5 were purchases and 10 were sales.

How many shares of Neuronetics are outstanding?

Neuronetics has 76.2M shares outstanding, of which 37.2M are in the public float.

Medical Devices: ownership